©The Author(s) 2025.
World J Hepatol. Nov 27, 2025; 17(11): 112364
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.112364
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.112364
Figure 2 Immune cell infiltration scores and survival analysis.
A: Volcano plot showing the differences in immune cell infiltration scores between the response and non-response groups; B-D: Kaplan-Meier curves for class-switched memory B cells (B), plasma cells (C) and pro-B cells (D), respectively, comparing high and low expression levels in the study population. FC: Fold change.
- Citation: Wang LJ, Cui Y, Huang LF, Zhang JQ, Zhao TT, Wang HW, Liu M, Jin KM, Wang K, Xing BC. Molecular biomarkers of sintilimab plus lenvatinib in hepatitis-B-virus-associated hepatocellular carcinoma. World J Hepatol 2025; 17(11): 112364
- URL: https://www.wjgnet.com/1948-5182/full/v17/i11/112364.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i11.112364